263 related articles for article (PubMed ID: 22249250)
1. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.
Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X
Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250
[TBL] [Abstract][Full Text] [Related]
2. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
3. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma.
Atkinson GP; Nozell SE; Harrison DK; Stonecypher MS; Chen D; Benveniste EN
Oncogene; 2009 Oct; 28(42):3735-45. PubMed ID: 19668231
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
5. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
[TBL] [Abstract][Full Text] [Related]
6. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP
Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
[TBL] [Abstract][Full Text] [Related]
8. FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.
Han B; Qu Y; Jin Y; Yu Y; Deng N; Wawrowsky K; Zhang X; Li N; Bose S; Wang Q; Sakkiah S; Abrol R; Jensen TW; Berman BP; Tanaka H; Johnson J; Gao B; Hao J; Liu Z; Buttyan R; Ray PS; Hung MC; Giuliano AE; Cui X
Cell Rep; 2015 Nov; 13(5):1046-58. PubMed ID: 26565916
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
Mott L; Su K; Pack DW
Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313
[TBL] [Abstract][Full Text] [Related]
10. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
[TBL] [Abstract][Full Text] [Related]
11. Pinning NF-kappaB to the nucleus.
Ben-Neriah Y
Mol Cell; 2003 Dec; 12(6):1344-5. PubMed ID: 14690587
[TBL] [Abstract][Full Text] [Related]
12. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
Zuo H; Yang Q
J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
[TBL] [Abstract][Full Text] [Related]
13. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.
Fan G; Fan Y; Gupta N; Matsuura I; Liu F; Zhou XZ; Lu KP; Gélinas C
Cancer Res; 2009 Jun; 69(11):4589-97. PubMed ID: 19458071
[TBL] [Abstract][Full Text] [Related]
17. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
18. Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma.
Shinoda K; Kuboki S; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
Br J Cancer; 2015 Nov; 113(9):1323-31. PubMed ID: 26461058
[TBL] [Abstract][Full Text] [Related]
19. The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury.
Kuboki S; Sakai N; Clarke C; Schuster R; Blanchard J; Edwards MJ; Lentsch AB
J Hepatol; 2009 Aug; 51(2):296-306. PubMed ID: 19515451
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.
Kanzaki H; Mukhopadhya NK; Cui X; Ramanujan VK; Murali R
Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):1-11. PubMed ID: 26871511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]